Co-Authors
This is a "connection" page, showing publications co-authored by ISSAM I RAAD and HARRYS ANTONIO TORRES.
Connection Strength
4.655
-
Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies. Medicine (Baltimore). 2022 Sep 16; 101(37):e30608.
Score: 0.854
-
Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. J Natl Compr Canc Netw. 2016 09; 14(9):1185-8.
Score: 0.562
-
Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. J Clin Virol. 2012 Jul; 54(3):218-22.
Score: 0.413
-
Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way. Clin Infect Dis. 2012 Mar 01; 54(5):740-2.
Score: 0.411
-
Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb; 27(2):195-7.
Score: 0.270
-
Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.
Score: 0.267
-
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26.
Score: 0.213
-
Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib. Clin Lymphoma Myeloma Leuk. 2020 03; 20(3):e124-e127.
Score: 0.177
-
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2019 02; 114(2):250-257.
Score: 0.166
-
Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World J Hepatol. 2018 Sep 27; 10(9):549-557.
Score: 0.162
-
Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50.
Score: 0.125
-
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7.
Score: 0.078
-
Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8.
Score: 0.077
-
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia. 2008 Mar; 22(3):496-503.
Score: 0.077
-
Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007 Sep; 92(9):1216-23.
Score: 0.075
-
Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007 Apr 01; 44(7):964-7.
Score: 0.072
-
Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8.
Score: 0.068
-
Cytomegalovirus pneumonia in patients with lymphoma. Cancer. 2005 Sep 15; 104(6):1213-20.
Score: 0.066
-
Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79.
Score: 0.066
-
Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7.
Score: 0.064
-
Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9.
Score: 0.058
-
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9.
Score: 0.057
-
Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003 Jul 01; 98(1):86-93.
Score: 0.056
-
Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8.
Score: 0.056
-
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
Score: 0.055
-
Nocardiosis in cancer patients. Medicine (Baltimore). 2002 Sep; 81(5):388-97.
Score: 0.053
-
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis. 2012 Nov; 206(9):1367-71.
Score: 0.027
-
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis. 2005 May; 52(1):15-20.
Score: 0.016
-
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21.
Score: 0.014